United States · FDA National Drug Code directory
Lithium Carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0021_5e0351f3-360d-4044-a40a-a36f0008cf92
- Product NDC
- 0054-0021
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Lithium Carbonate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20041028
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0054-0021-25) · 0054-0021-25
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0054-0021-29) · 0054-0021-29
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →